TREATMENT OF SEIZURES AND STATUS EPILEPTICUS IN INTENSIVE CARE UNIT OF GENERAL PEDIATRIC HOSPITAL: EXPERIENCE OF USE OF INTRAVENOUS VALPROIC ACID
- 作者: Schederkina I.O1,2, Maslova N.A1,2, Semenova L.P1, Koltunov I.E1,3, Petryaikina E.E1,3, Zavadenko N.N.1,2
-
隶属关系:
- SBHCIMHCD Morozov Children's City Clinical Hospital
- SBEIHPE RNSMU n.a. N.I. Pirogov of RMH
- Peoples' Friendship University of Russia
- 期: 编号 11 (2016)
- 页面: 61-67
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/289071
- ID: 289071
如何引用文章
详细
全文:
作者简介
I. Schederkina
SBHCIMHCD Morozov Children's City Clinical Hospital; SBEIHPE RNSMU n.a. N.I. Pirogov of RMH
Email: schederkina@bk.ru
PhD, Head of the Center for the treatment of cerebrovascular pathology in children and adolescents; an Assistant Professor at the Department of Neurology, Neurosurgery and Medical Genetics of Faculty of Pediatrics Moscow
N. Maslova
SBHCIMHCD Morozov Children's City Clinical Hospital; SBEIHPE RNSMU n.a. N.I. Pirogov of RMHMoscow
L. Semenova
SBHCIMHCD Morozov Children's City Clinical HospitalMoscow
I. Koltunov
SBHCIMHCD Morozov Children's City Clinical Hospital; Peoples' Friendship University of RussiaMoscow
E. Petryaikina
SBHCIMHCD Morozov Children's City Clinical Hospital; Peoples' Friendship University of RussiaMoscow
N. Zavadenko
SBHCIMHCD Morozov Children's City Clinical Hospital; SBEIHPE RNSMU n.a. N.I. Pirogov of RMHMoscow
参考
- Карлов В.А. Эпилепсия у детей и взрослых, женщин и мужчин. М., 2010. 720 с.
- Карлов В.А. Судорожный эпилептический статус. М., 2003. 166 с.
- Федеральное руководство по детской неврологии / Под ред. В.И. Гузевой. М., 2016. 656 с.
- Эпилептология детского возраста. Руководство для врачей / Под ред. А.С. Петрухина. М., 2000. 624 с.
- Panteliadis Ch.P., Korinthenberg R. Paediatric Neurologi, theory and practice. G. Thieme Verlag, Stuttgart-New York, 2005. 974 p.
- Заболевания нервной системы у детей / Под ред. Ж. Айкрди. М., 2013. Т. 1. 644-50.
- Panayiotopoulos C.P. The Epilepsies: seizures, syndromes and management. Blandon Med. Publishing, Oxfordshire. 2005. 578.
- Sasidaran K., Singhi S., Singhi P. Management of acute seizure and status epilepticus in pediatric emergency. Indian J. Pediatr. 2012; 79(4):510-17.
- Malamiri R.A., Ghaempanah M., Khosroshahi N. Efficacy and safety of intravenous sodium valproate versus phénobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Eur. J. Paediatr. Neurol. 2012; 16(5):536-41.
- Mehta V., Singhi P., Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J. Child. Neurol. 2007;22(10):1191-97.
- Appleton R., Martland T., Phillips B. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst. Rev. 2002;(4):CD001905.
- Capovilla G., Beccaria F., Beghi E., Minicucci F., Sartori S., Vecchi M. Treatment of convulsive status epilepticus in childhood: recommendations of the Italian League Against Epilepsy. Epilepsia. 2013;54(Suppl. 7):23-34.
- Glauser T., Shinnar Sh., Gloss D., et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Currents. 2016; 16(1):48-61.
- Pohlmann-Eden B., Peters CAN. 2001, Management of Status epilepticus. Neuronews. The Neurology Portal. 2008;7.
- Alvarez V., Januel J.M., Burnand. Second-line status epilepticus treatment: comparison of phenytoin, valproate and levetiraceta. Epilapsia. 2011;52(7):1292-96.
- Bertsche A., Neininger M.P., Dahse A.J., Syrbe S. Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness. Eur. J. Pediatr. 2014;173(1):87-92.
- Limdi N.A., Shimpi A.V., Faught E., et al. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology. 2005; 64(2):353-55.